22nd Century Group Receives Order for Nearly 5 Million SPECTRUM® U.S. Government Research Cigarettes
September 09 2015 - 11:07AM
Business Wire
22nd Century Group, Inc. (NYSE MKT: XXII), a leader in
tobacco harm reduction, announced today that its wholly-owned
subsidiary, Goodrich Tobacco Company, received a purchase order for
4.95 million SPECTRUM U.S. government research cigarettes.
22nd Century developed SPECTRUM in partnership with independent
researchers and officials from the National Institute on Drug Abuse
(NIDA), the U.S. Food and Drug Administration (FDA), the National
Cancer Institute (NCI) and the Centers for Disease Control and
Prevention (CDC). The main SPECTRUM product line, uniquely produced
by 22nd Century, consists of a series of cigarette styles that vary
nicotine yields over a 50-fold range – from very low (97% less
nicotine than conventional brands) to relatively high nicotine
yields. SPECTRUM features 24 styles, in both regular and menthol
versions, with 8 levels of nicotine in its tobacco.
Including this order, Goodrich Tobacco has received orders for
more than 22 million SPECTRUM cigarettes. SPECTRUM cigarettes
are not sold commercially; they are produced by 22nd Century from
its proprietary and patented technology for exclusive use in
independent clinical research.
Ongoing clinical research conducted with SPECTRUM cigarettes
includes: (i) exposure studies comparing how different nicotine
levels in cigarettes affect smoking behavior and exposure to smoke
compounds, (ii) smoking cessation studies, and (iii) studies to
determine whether there is a threshold nicotine level in cigarettes
which does not produce dependence. Without SPECTRUM these
clinical studies would be very difficult, if not impossible, to
conduct. Notably, 22nd Century is the only company in the world
capable of producing the Very Low Nicotine SPECTRUM brand
styles.
Using the results from independent clinical research studies
with Very Low Nicotine cigarettes, 22nd Century intends to become
the first company in the world authorized by the FDA to market
reduced exposure combustible cigarettes.
“22nd Century’s highly specialized SPECTRUM research cigarettes,
our proprietary 'Brand A' Very Low Nicotine cigarettes, and our
extraordinary MAGIC 0 Very Low Nicotine cigarettes all contribute
to advancing our Company’s core mission: To Reduce the Harm Caused
by Smoking,” explained Henry Sicignano, III, President and CEO of
22nd Century Group. “We are very proud to be a part of such
important public health nicotine research efforts and at the
forefront of reduced exposure cigarette product development.”
About 22nd Century Group, Inc.
22nd Century Group is a plant biotechnology company focused on
technology which allows it to increase or decrease the level of
nicotine in tobacco plants through genetic engineering and plant
breeding. The Company’s mission is to reduce the harm caused by
smoking. 22nd Century currently owns or exclusively controls more
than 185 issued patents and more than an additional 54 pending
patent applications around the world. The Company’s strong IP
position led to a licensing agreement with British American Tobacco
(“BAT”), the world’s second largest tobacco company. Visit
www.xxiicentury.com for more information.
Cautionary Note Regarding Forward-Looking Statements: This press
release contains forward-looking information, including all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of 22nd Century Group, Inc.,
its directors or its officers with respect to the contents of this
press release. The words “may,” “would,” “will,” “expect,”
“estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify
forward-looking statements. We cannot guarantee future results,
levels of activity or performance. You should not place undue
reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should
be considered with any written or oral forward-looking statements
that we may issue in the future. Except as required by applicable
law, including the securities laws of the United States, we do not
intend to update any of the forward-looking statements to conform
these statements to reflect actual results, later events or
circumstances, or to reflect the occurrence of unanticipated
events. You should carefully review and consider the various
disclosures made by us in our annual report on Form 10-K for the
year ended December 31, 2014, filed on February 6, 2015, including
the section entitled “Risk Factors,” and our other reports filed
with the U.S. Securities and Exchange Commission which attempt to
advise interested parties of the risks and factors that may affect
our business, financial condition, results of operation and cash
flows. If one or more of these risks or uncertainties materialize,
or if the underlying assumptions prove incorrect, our actual
results may vary materially from those expected or projected.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150909006273/en/
Investor Relations:For 22nd Century Group, Inc.Andrew
Haag, 866-976-4784xxii@irthcommunications.comorRedington, Inc.Tom
Redington, 203-222-7399
22nd Century (AMEX:XXII)
Historical Stock Chart
From Mar 2024 to Apr 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Apr 2023 to Apr 2024